⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15009251 | 0.82 | — | — | |
| SCHEMBL29153222 | 0.79 | — | — | |
| SCHEMBL2346990 | 0.79 | — | — | |
| SCHEMBL13748700 | 0.76 | — | — | |
| SCHEMBL126090 | 0.74 | — | — | |
| SCHEMBL18051491 | 0.73 | — | — | |
| SCHEMBL12334043 | 0.70 | — | — | |
| SCHEMBL11760806 | 0.70 | — | — | |
| Hydrogen Sulfide SCHEMBL9309670 | 0.70 | ALDH1A1 (0.33) | — | |
| SCHEMBL2788740 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9426989-B2 | Organic peroxide compounds for microorganism inactivation | NOVARTIS AG (CH) | 2016-08-30 | — | — | US | claimed |
| US-20130149194-A1 | ORGANIC PEROXIDE COMPOUNDS FOR MICROORGANISM INACTIVATION | NOVARTIS VACCINES AND DIAGNOSTICS GMBH (DE) | 2013-06-13 | — | — | US | claimed |
| EP-2566323-A2 | ORGANIC PEROXIDE COMPOUNDS FOR MICROORGANISM INACTIVATION | Novartis AG (CH) | 2013-03-13 | — | — | EP | claimed |
| WO-2011138682-A2 | ORGANIC PEROXIDE COMPOUNDS FOR MICROORGANISM INACTIVATION | NOVARTIS AG (CH) | 2011-11-10 | — | — | WO | claimed |
| CN-113764736-B | Electrolyte for lithium ion battery, preparation method of electrolyte and lithium ion battery | 深圳市研一新材料有限责任公司 | 2024-02-06 | — | — | CN | disclosed |
| US-9426989-B2 | Organic peroxide compounds for microorganism inactivation | NOVARTIS AG (CH) | 2016-08-30 | — | — | US | disclosed |
| US-9426989-B2 | Organic peroxide compounds for microorganism inactivation | NOVARTIS AG (CH) | 2016-08-30 | — | — | US | disclosed |
| US-9426989-B2 | Organic peroxide compounds for microorganism inactivation | NOVARTIS AG (CH) | 2016-08-30 | — | — | US | disclosed |
| CN-104693146-A | Continuous process for the epoxidation of olefinic compound with oxidant | SOUTH BANK UNIV ENTPR LTD | 2015-06-10 | — | — | CN | disclosed |
| CN-102596924-B | Continuous process for the liquid phase epoxidation of an olefin compound with an oxidant | SOUTH BANK UNIV ENTPR LTD | 2015-02-11 | — | — | CN | disclosed |
| US-20130149194-A1 | ORGANIC PEROXIDE COMPOUNDS FOR MICROORGANISM INACTIVATION | NOVARTIS VACCINES AND DIAGNOSTICS GMBH (DE) | 2013-06-13 | — | — | US | disclosed |
| US-20130149194-A1 | ORGANIC PEROXIDE COMPOUNDS FOR MICROORGANISM INACTIVATION | NOVARTIS VACCINES AND DIAGNOSTICS GMBH (DE) | 2013-06-13 | — | — | US | disclosed |
| EP-2566323-A2 | ORGANIC PEROXIDE COMPOUNDS FOR MICROORGANISM INACTIVATION | Novartis AG (CH) | 2013-03-13 | — | — | EP | disclosed |
| CN-102596924-A | Process for the preparation of a coating | SOUTH BANK UNIV ENTPR LTD | 2012-07-18 | — | — | CN | disclosed |
| WO-2011138682-A2 | ORGANIC PEROXIDE COMPOUNDS FOR MICROORGANISM INACTIVATION | NOVARTIS AG (CH) | 2011-11-10 | — | — | WO | disclosed |
| EP-1222929-B1 | Method and pharmaceutical composition for preventing and/or treating systemic inflammatory response syndrome | D COLLEN RES FOUNDATION VZW (BE) | 2010-05-19 | — | — | EP | disclosed |